ILC Dover

http://www.pharmtech.com/pt_w/pharma_facilities


	Contamination control has always been a leading concern for bio/pharmaceutical facilities and operations. Facility and HVAC design, process workflows, and standard operating procedures for personnel and equipment are all designed to protect the product and people.

	The COVID-19 pandemic requires bio/pharma companies to look beyond good manufacturing practices to assess the how the potential spread of the virus may impact different areas of development and manufacturing facilities, employees, visitors, and product.

	In this webcast, experts will review strategies for evaluating practices at existing facilities and will discuss options for designing new facilities that can accommodate future needs, including flexibility requirements and any emerging threats. 

		Moving beyond basic maintenance procedures

		Using airflow modeling and simulation to optimize manufacturing, personnel, and material flow 

		Strategies for rapid process scale up, changeovers, and return to full capacity

		Implementing science-based design principles for innovative, affordable facility designs

	This Editors’ Series webcast is presented by 

 magazine, in conjunction with INTERPHEX.

Jason S. Collins, AIA, Director, Process Architecture, IPS

	Curt Firestine, Mechanical Engineer, CRB

Tuesday, May 26, 2020 at 2 pm EDT| 1pm CDT| 11am PDT

	On demand available after airing until May 26, 2021

Webcasts

The COVID-19 pandemic should prompt bio/pharma facilities to assess how the potential spread of the virus may impact different areas of development and manufacturing facilities, employees, visitors, and product. Learn about strategies for evaluating practices at existing facilities and options for designing new facilities that can accommodate future needs, including flexibility requirements and any emerging threats. 

Live: Tuesday, May 26, 2020 at 2 pm EDT| 1pm CDT| 11am PDT

On demand available after airing until May 26, 2021

Register free



ILC Dover

Articles